GlassScriptPhysician profile
Samer Thanavaro
NPI 1619960606
$3,707.74
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $819 · 2020: $584 · 2021: $886 · 2022: $804 · 2023: $462 · 2024: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $614.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $614.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,024.43 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $479.56 | 2019-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $310.18 | 2021-2023 | Verquvo |
| Sanofi-Aventis U.S. LLC | $214.66 | 2020-2023 | |
| Amarin Pharma, INC. | $213.03 | 2019-2021 | |
| Amgen INC. | $190.05 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $182.02 | 2019-2023 | Eliquis |
| Pfizer INC. | $180.91 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $167.35 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $154.90 | 2019-2022 | |
| Abbott Laboratories | $152.12 | 2024 | Amplatzer Amulet |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $122.89 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $60.59 | 2021-2023 | |
| Esperion Therapeutics, INC. | $53.35 | 2023 | Nexletol |
| Kestra Medical Technology Services, INC. | $33.54 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $29.34 | 2023 | Inpefa |
| Cvrx, INC. | $25.97 | 2022 | |
| Medtronic Vascular, INC. | $22.92 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $22.78 | 2019 | |
| Vifor Pharma, INC. | $19.07 | 2019 | |
| Bardy Diagnostics, INC. | $19.00 | 2022 | |
| Impulse Dynamics (USA) INC. | $15.82 | 2022 | |
| Angiodynamics, INC. | $13.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samer Thanavaro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.